Alan Niederman

1.4k total citations
15 papers, 899 citations indexed

About

Alan Niederman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alan Niederman has authored 15 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alan Niederman's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Coronary Interventions and Diagnostics (4 papers) and Heart Failure Treatment and Management (4 papers). Alan Niederman is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Coronary Interventions and Diagnostics (4 papers) and Heart Failure Treatment and Management (4 papers). Alan Niederman collaborates with scholars based in United States, Belgium and Australia. Alan Niederman's co-authors include Robert A. Harrington, Mark Tannenbaum, Dean J. Kereiakes, Diane Joseph‐McCarthy, Nicholas Lembo, David J. Moliterno, Gary S. Roubin, Spencer B. King, John Strony and Enrico P. Veltri and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Alan Niederman

15 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Niederman United States 10 647 538 220 195 165 15 899
Tomiyoshi Saito Japan 13 437 0.7× 230 0.4× 118 0.5× 98 0.5× 157 1.0× 34 718
Wolfgang Schmidt Germany 10 639 1.0× 382 0.7× 117 0.5× 285 1.5× 178 1.1× 18 994
Douglas H. Israel United States 16 619 1.0× 602 1.1× 87 0.4× 282 1.4× 249 1.5× 30 1.0k
Gianfranco Percoco Italy 17 1.7k 2.6× 1.3k 2.4× 201 0.9× 273 1.4× 143 0.9× 26 2.0k
Peter Steele United States 18 430 0.7× 280 0.5× 59 0.3× 113 0.6× 180 1.1× 39 781
Joseph G. Motwani United Kingdom 9 597 0.9× 645 1.2× 50 0.2× 73 0.4× 156 0.9× 13 1.0k
W. Huhmann Germany 7 499 0.8× 295 0.5× 148 0.7× 154 0.8× 189 1.1× 15 784
Michel Pansiéri France 10 1.2k 1.8× 797 1.5× 259 1.2× 316 1.6× 66 0.4× 28 1.3k
Jei Keon Chae South Korea 18 755 1.2× 531 1.0× 96 0.4× 206 1.1× 68 0.4× 73 1.1k
Marc Laine France 17 818 1.3× 394 0.7× 213 1.0× 88 0.5× 47 0.3× 62 1.0k

Countries citing papers authored by Alan Niederman

Since Specialization
Citations

This map shows the geographic impact of Alan Niederman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Niederman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Niederman more than expected).

Fields of papers citing papers by Alan Niederman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Niederman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Niederman. The network helps show where Alan Niederman may publish in the future.

Co-authorship network of co-authors of Alan Niederman

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Niederman. A scholar is included among the top collaborators of Alan Niederman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Niederman. Alan Niederman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Becker, Richard C., David J. Moliterno, Lisa K. Jennings, et al.. (2009). Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study. The Lancet. 373(9667). 919–928. 222 indexed citations
3.
4.
Costa, Marco A., Dominick J. Angiolillo, Mark Tannenbaum, et al.. (2008). Impact of Stent Deployment Procedural Factors on Long-Term Effectiveness and Safety of Sirolimus-Eluting Stents (Final Results of the Multicenter Prospective STLLR Trial). The American Journal of Cardiology. 101(12). 1704–1711. 167 indexed citations
5.
Gibson, C. Michael, Cafer Zorkun, Peter Molhoek, et al.. (2006). Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: Results of the TIMI 31 trial. Journal of Thrombosis and Thrombolysis. 22(1). 13–21. 6 indexed citations
6.
Lincoff, A. Michael, John A. Bittl, Neal S. Kleiman, et al.. (2004). Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). The American Journal of Cardiology. 93(9). 1092–1096. 164 indexed citations
7.
McClean, Dougal R., Hamid Ikram, J. Thomas Heywood, et al.. (2002). Vasopeptidase inhibition with omapatrilat in chronic heart failure: acute and long-term hemodynamic and neurohumoral effects. Journal of the American College of Cardiology. 39(12). 2034–2041. 21 indexed citations
8.
Klapholz, Marc, Ignatius Thomas, Calvin Eng, et al.. (2001). Effects of omapatrilat on hemodynamics and safety in patients with heart failure. The American Journal of Cardiology. 88(6). 657–661. 10 indexed citations
9.
Matthai, William, Alan Niederman, Lawrence A. Barr, et al.. (2000). Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first".. PubMed. 12 Suppl A. 1A–5A. 38 indexed citations
10.
Gavras, Haralambos, Steven G. Chrysant, Alan Niederman, et al.. (1998). Evaluation of Enalapril Combined with Diltiazem Er in Patients with Stage 3–4 Essential Hypertension. Clinical and Experimental Hypertension. 20(1). 41–52. 1 indexed citations
11.
Klapholz, Marc, Ignatius Thomas, Calvin Eng, et al.. (1998). Omapatrilat, a novel cardiovascular agent, improves hemodynamics in patients with heart failure. Journal of Cardiac Failure. 4(3). 41–41. 4 indexed citations
12.
Chrysant, Steven G., et al.. (1997). Clinical Utility of Long‐Term Enalapril/Diltiazem ER in Stage 3–4 Essential Hypertension. The Journal of Clinical Pharmacology. 37(9). 810–815. 7 indexed citations
13.
14.
Black, Alexander, Alan Niederman, Nicholas Lembo, et al.. (1989). Tear or dissection after coronary angioplasty. Morphologic correlates of an ischemic complication.. Circulation. 79(5). 1035–1042. 95 indexed citations
15.
Lembo, Nicholas, et al.. (1987). Fatal aortic rupture during percutaneous balloon valvuloplasty for valvular aortic stenosis. The American Journal of Cardiology. 60(8). 733–736. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomiyoshi Saito Breakdown of academic impact, for papers by Wolfgang Schmidt Breakdown of academic impact, for papers by Douglas H. Israel Breakdown of academic impact, for papers by Gianfranco Percoco Breakdown of academic impact, for papers by Peter Steele Breakdown of academic impact, for papers by Joseph G. Motwani Breakdown of academic impact, for papers by W. Huhmann Breakdown of academic impact, for papers by Michel Pansiéri Breakdown of academic impact, for papers by Jei Keon Chae Breakdown of academic impact, for papers by Marc Laine
Rankless by CCL
2026